About Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V.
During the past decade, Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V. conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 13 clinical trials were completed, i.e. on
average, 44.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 13 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V." #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Shire" with 4 trials
sponsored, "Celgene" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Ferring Pharmaceuticals"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V."
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Seagen Inc." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V.
According to Clinical.Site data, the most researched conditions in "Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V." are
"Systemic Lupus Erythematosus" (6 trials), "Ulcerative Colitis" (6 trials), "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V." in a lesser frequency.
Clinical Trials Intervention Types at Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V.
Most popular intervention types in "Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V." are "Drug" (27 trials), "Other" (7 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "Ontamalimab" (3 trials), "Ozanimod" (3 trials), "Acthar Gel" (2 trials) and "BMS-986165" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V.
The vast majority of trials in "Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V." are
29 trials for "All" genders.
Clinical Trials Status at Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V.
Currently, there are NaN active trials in "Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V.".
undefined are not yet recruiting,
8 are recruiting,
7 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 8 completed trials in Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V.,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V., 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".